Find uplifting stories about heroes, innovations, and solutions
2 results for "neuroinflammation"
A Cambridge biotech just secured $5 million to fast-track a groundbreaking Alzheimer's treatment that targets brain inflammation instead of protein buildup. The therapy could help millions by addressing a root cause that's been overlooked for decades.
Researchers at the University of Southern California have created compounds that could calm brain inflammation tied to Alzheimer's disease while preserving normal brain function. The breakthrough targets a specific enzyme elevated in people with the APOE4 gene, the strongest genetic risk factor for the disease.